logo
Do Food Expiration Dates Really Matter?

Do Food Expiration Dates Really Matter?

New York Times4 hours ago
When you open your fridge, how often do you check the dates on your food? The yogurt container says it's still good for a few more days, but the label on the half-used barbecue sauce says it was best before last Sunday. Should you still eat it?
The answer is complicated. Dates on food packaging usually indicate when food tastes best, not when it's unsafe to eat. In the United States, there are roughly 50 variations of date labels, including 'use by,' 'sell by' and 'packaged on,' nearly all of which indicate when quality or freshness begins declining.
While it's important to mind the printed dates for some foods, an estimated three billion pounds of food get thrown away each year because of confusion over the date label, according to the food waste nonprofit ReFED. Infant formula is the only product that has standardized, federally regulated date labels, leaving lots of questions about when to toss other aging perishables.
Here's what you should know.
A confusing array of tests
In the early to mid-1900s, American households began transitioning from locally grown food toward processed and packaged goods, and some producers began putting dates on their products to ease concerns about freshness. But these labels didn't become widespread until the 1960s and '70s, alongside broader efforts to improve nutrition labeling and transparency.
Today, individual food companies still determine what date goes on their products. But each uses its own methodology, said Londa Nwadike, a food science professor at South Dakota State University.
For instance, she said, some companies might use mathematical models to forecast when freshness declines, while others might conduct special tests wherein food is stored in hotter temperatures, high humidity or increased oxygen levels. Still others might expose a product to mold, yeast or pathogens like E. coli or salmonella. Some companies can't afford to run extensive tests and may simply base their dates on those of competitors.
Want all of The Times? Subscribe.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pearl Expands AI Integration with Curve Dental to Include Practice Intelligence
Pearl Expands AI Integration with Curve Dental to Include Practice Intelligence

Yahoo

time24 minutes ago

  • Yahoo

Pearl Expands AI Integration with Curve Dental to Include Practice Intelligence

Curve's leading practice management platform now delivers both real-time clinical diagnostics and powerful operational insights natively powered by Pearl AI LOS ANGELES, August 19, 2025--(BUSINESS WIRE)--Pearl, the global leader in dental AI solutions, and Curve Dental®, the premier provider of cloud-based dental practice management software, today announced the expansion of their integration to include Pearl's Practice Intelligence®. This AI-powered analytics solution helps dental practices surface opportunities for improved care, increased production, and stronger operational efficiency. This expanded partnership builds on the successful integration of Pearl's Second Opinion® radiologic AI capabilities within Curve Dental's SuperHero™ platform. With the addition of Practice Intelligence, Curve Dental's 80,000+ users across the United States and Canada now have seamless access to both real-time radiologic support and comprehensive AI-driven practice analytics within a single, unified interface. "Curve has always been committed to delivering the tools our customers need to grow smarter, more successful practices," said Jana Macon, Curve Dental President. "By expanding our relationship with Pearl to include Practice Intelligence, we're empowering our users with instant, actionable insights that help them make informed clinical and business decisions every day. It's another step forward in Curve's mission to provide future-ready solutions for today's dental teams." Pearl's Practice Intelligence uses AI to continuously monitor radiographic data, treatment plans, and patient records. The platform identifies patterns and opportunities to: Uncover undiagnosed and untreated patient conditions Surface provider and location-level performance metrics Standardize clinical output across providers Optimize scheduling, recall, and case acceptance efforts Increase production per patient By integrating Practice Intelligence directly into Curve SuperHero, dental organizations can now move from diagnosis to action with greater clarity. Practices gain access to smarter decision-making tools that enhance every stage of the patient journey and overall business operations. "We're excited to deepen our collaboration with Curve by bringing Practice Intelligence to their community," said Ophir Tanz, CEO of Pearl. "This integration delivers on the vision of intelligent practice management, where diagnostics, analytics, and decision support work together to help dental teams raise the standard of care and performance across the board." Want to supercharge Curve with Pearl's Practice Intelligence®? Click here to learn more. About Pearl Pearl is an AI-driven company committed to enhancing patient care in dentistry. Founded in 2019 by a team with decades of experience developing successful, enterprise-grade computer vision solutions, Pearl introduced the first-ever FDA-cleared AI capable of reading and instantly identifying diseases in dental x-rays. With regulatory clearance in 120 countries, Pearl's AI assists dentists in making precise clinical decisions and effectively communicating with patients, thereby transforming the dental care experience worldwide. As dentistry's global AI leader, Pearl is committed to the ongoing innovation of robust, accessible AI tools that improve patient health outcomes and build greater trust in dental medicine. To request a demo, please visit About Curve Dental Curve Dental provides the leading cloud-based practice management software for over 80,000 dental professionals across the United States and Canada. From the start, Curve Dental has been singularly focused on the dental industry and is committed to delivering the best all-in-one dental practice management and patient engagement software for practices of all sizes. The company is privately-held, with offices in Provo, Utah; Atlanta, Georgia; Calgary, Alberta; and Aberdeen, Scotland. Visit or call 1-888-910-HERO for more information. View source version on Contacts Media Contacts Kate Gundrypearl@ +1 617-797-5174 Shahrzad

Novo Nordisk, Eli Lilly rise after Viking obesity trial data
Novo Nordisk, Eli Lilly rise after Viking obesity trial data

Yahoo

time24 minutes ago

  • Yahoo

Novo Nordisk, Eli Lilly rise after Viking obesity trial data

-- Novo Nordisk and Eli Lilly (NYSE:LLY) shares edged higher Tuesday following results from Viking Therapeutics' Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment. Novo Nordisk (NYSE:NVO) rose 1.4% premarket, while Eli Lilly gained 1.2%. Viking Therapeutics (NASDAQ:VKTX) plunged over 30% in premarket trading. The trial tested Viking's oral tablet VK2735, a dual GLP-1 and GIP receptor agonist, and met its primary endpoint, with patients losing up to 12.2% of body weight after 13 weeks versus 1.3% for placebo. However, a 28% treatment discontinuation rate among VK2735 recipients raised concerns, compared with 18% in the placebo group. Viking said 99% of gastrointestinal-related adverse events were mild or moderate, and an exploratory maintenance dosing arm indicated weight loss could be maintained at lower doses. Mizuho analyst Jared Holz said the data highlighted challenges relative to Eli Lilly's offerings. 'Data look inferior to LLY on almost all metrics and the thing to consider here is that patients discontinued at such a high rate over 13-weeks vs. LLY in the mid 20% range — but over 72-weeks; a much longer trial, and therefore LLY looks far better head-to-head,' Holz wrote. He added that Viking would likely need pipeline improvements or enhanced formulations to regain investor interest. 'A tough day for retail investors ahead – that have been pumping this thing like a 1991 Reebok Dee Brown," concluded Holz. The results underscore the competitive pressure in the oral obesity market. Related articles Novo Nordisk, Eli Lilly rise after Viking obesity trial data Tesla: Hype Aside, How Much Is the EV Giant Really Worth Now? Apollo economist warns: AI bubble now bigger than 1990s tech mania Sign in to access your portfolio

Prenatal Exposure to Pesticide Linked to Brain Abnormalities
Prenatal Exposure to Pesticide Linked to Brain Abnormalities

Medscape

time25 minutes ago

  • Medscape

Prenatal Exposure to Pesticide Linked to Brain Abnormalities

Higher prenatalexposure to a common pesticide, chlorpyrifos (CPF), was associated with a greater likelihood of brain abnormalities and poorer motor function among children aged 6 to almost 15 years in a prospective, longitudinal study. MRIs revealed widespread brain changes, including thicker frontal, temporal, and posterior inferior cortices; reduced white matter volumes; and lower diffusivity of internal capsule white matter. Researchers also observed that prenatal CPF exposure levels were linked to lower indices of neuronal density in white matter tracts and lower performance on fine motor and motor programming tasks. Previous preclinical and clinical studies supported the neurotoxicity of CPF, but this is the first research to look at specific brain changes in people. 'These are very strong associations such that progressively higher levels of exposure are associated with progressively greater disruptions in development of brain structure and metabolism, as well as greater disruptions in motor control,' lead author Bradley S. Peterson, MD, division chief of psychiatry and behavioral sciences at Children's Hospital Los Angeles, Los Angeles, told Medscape Medical News . The study was published online on August 18 in JAMA Neurology . Measuring an Enduring Effect CPF is a chlorinated organophosphate and one of the most common pesticides used globally. It enters the bloodstream through ingestion or skin contact or after breathing it in. In pregnant women, the pesticide crosses the placenta, enters the fetal bloodstream, reaches concentrations up to four times higher than those in the mother's circulation, and crosses the fetal blood-brain barrier. 'Pregnancy is an exquisitely sensitive period of brain development that is vulnerable to environmental exposures, including CPF,' Peterson said. 'Protecting unborn children by advocating for restrictions on pesticide use and by educating prospective parents on measures to reduce exposure is essential.' From January 1998 to July 2006, investigators recruited 727 pregnant African American or Dominican women living in northern New York City. Between 2007 and 2015, MRI scans were performed on 332 of their children aged 6-14.7 years. Researchers compared MRI findings to CPF levels in umbilical cord or maternal blood, analyzing data between February 2018 and November 2024 on a final cohort of 270 children (median age, 10.38 years). Maternal exposure to CPF in participants was primarily from spraying indoors for pests, which was prevalent in this inner-city neighborhood before residential use was banned in 2001, the authors noted. Widespread Brain Changes Peterson said a surprising study outcome was 'how strong and widespread across the brain these associations were' spanning measures of cortical thickness, white matter myelination, neuronal density, and metabolism. On an MRI, for example, CPF exposure was associated significantly and positively with cortical thickness in frontal regions, including the superior, middle, and inferior frontal gyrus; the anterior cingulate cortex; gyrus rectus; and the middle orbitofrontal and lateral orbitofrontal gyrus. The same associations were seen in temporal brain regions, including the superior, middle, and inferior temporal gyrus, and the parahippocampus. Posteroinferior regions altered the same way, including the posterior cingulate cortex, cuneus, and the inferior occipital, lingual, and fusiform gyrus. In contrast, CPF levels were associated with lower cortical thickness in the dorsal parietal region, specifically the superior parietal gyrus, and with lower white matter volumes in multiple frontal, temporal, and posteroinferior regions. In addition to the anatomic MRI findings, magnetic resonance spectroscopic imaging showed that CPF exposure associated inversely with N-acetyl-L-aspartate, which reflects neuron density, in scattered foci within deep white matter tracts and in gray matter of the insular cortex. Diffusion tensor imaging also positively linked CPF exposure to fractional anisotropy and inversely with average diffusion coefficient values in the internal capsule. Furthermore, arterial spin labeling revealed higher CPF exposure was associated with a lower regional cerebral blood flow. 'In this cohort study, progressively higher prenatal CPF exposure levels associated significantly with progressively greater alterations in brain measures in each MRI modality, suggesting that prenatal exposure may produce enduring disturbances in brain structure, function, and metabolism in direct proportion to exposure level,' investigators wrote. Inflammation and Oxidative Stress Likely Culprits Another unexpected result for Peterson was how similar the CPF findings were to those linked to other prenatal exposures, including air pollution, despite being extremely different chemicals. This suggests a common pathway for disrupting brain development, 'most likely by producing inflammation and oxidative stress in the brain, which are toxic to brain cells early in development,' he said. Asked about treating children already affected by CPF, Peterson replied, 'Unfortunately, we don't know yet of ways to help children who are already exposed. The only ways we know currently to mitigate risk to unborn children is to minimize exposures.' He added, 'Perhaps in the future, novel therapeutics may reduce inflammation and oxidative stress from CPF and other pesticide exposures and thereby attenuate their adverse effects on brain development.' Use Remains Controversial CPF is 'ubiquitous' on nonorganic fruit, vegetables, and grains, added Peterson, who is also vice chair for research and chief of the Division of Child and Adolescent Psychiatry at the Keck School of Medicine of USC in Los Angeles. The pesticide is also carried by outdoor air and is often used in agriculture. 'Farm families are at particularly high risk because pregnant women not only work in the fields but also live in nearby communities, where pesticide drift is common,' said senior investigator Virginia A. Rauh, ScD, the Jane and Alan Batkin Professor of Population and Family Health at Columbia Mailman School of Public Health in New York City. 'This is an area where public health policy changes would have a significant impact,' she added. There are federal and state restrictions. In August 2021, the US Environmental Protection Agency (EPA) removed all 'tolerances' or acceptable levels of CPF on food. Several agricultural groups challenged the action, and in December 2023, a US Circuit Court vacated the earlier EPA decision. The agency is now considering a final rule that would restrict exposures for farm workers and vulnerable populations and set limits for the pesticide on 11 specific crops: alfalfa, apple, asparagus, tart cherry, citrus, cotton, peach, soybean, strawberry, sugar beet, and spring and winter wheat. State laws on CPF use vary. 'Surprisingly,' Rauh said, 'CPF is banned in only five states: California, Hawaii, New York, Maryland, and Oregon.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store